Esperion Therapeutics, Inc. (ESPR) Stock Analysis

Free AI-powered analysis and research for Esperion Therapeutics, Inc. stock

Sector: Healthcare

Analyze Esperion Therapeutics, Inc. (ESPR) Stock

Esperion Therapeutics, Inc. (ESPR) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ESPR stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Esperion Therapeutics, Inc. stock.

📰 Latest Update

ESPR Stock Surges 44% in a Month: Here's What You Need to Know

Thu, May 14, 2026 at 2:44 PM UTC 4 min read

ESPR stock has surged 44% over the past month, driven by positive developments surrounding its cardiovascular drug pipeline and encouraging clinical trial results. This significant price increase highlights growing investor confidence in the company's potential for future revenue growth and market expansion. As ESPR continues to advance its product offerings, investors may see increased opportunities for returns in the evolving healthcare sector.

Read full article →

Why Analyze Esperion Therapeutics, Inc. (ESPR) with StockIQ?

• ✅ Free AI-powered analysis of Esperion Therapeutics, Inc. (ESPR) stock
• ✅ Real-time technical indicators for Esperion Therapeutics, Inc. stock
• ✅ Comprehensive risk assessment for ESPR
• ✅ No credit card required

People also watch